首页> 中文期刊> 《基层医学论坛》 >得宝松复合液神经阻滞治疗原发性三叉神经痛的临床分析

得宝松复合液神经阻滞治疗原发性三叉神经痛的临床分析

         

摘要

Objective To investigate the clinical outcomes of treatment of trigeminal neuralgia with nerve block through diprospan mixture.Methods Sixty-four patients with trigeminal neuralgia,according to the risk branches respectively with diprospan mixture line supraorbital,infraorbital and/or mandibular nerve block.Results The excellent, effective and ineffective efficacy rates were 73.4%(47/64 cases),20.3%(13/64 cases) and 6.3%(4/64 cases) respectively 1 course of the treatment.Conclusion Diprospan mixture nerve block is one of the effective methods of the treatment of trigeminal neuralgia.%  目的探讨得宝松复合液神经阻滞治疗原发性三叉神经痛的临床疗效.方法64例原发性三叉神经痛患者根据罹患分支分别采用得宝松复合液行眶上、眶下和(或)下颌神经阻滞.结果64例患者经过1个疗程的治疗,显效47例(73.4%),有效13例(20.3%),无效4例(6.3%).结论得宝松复合液神经阻滞是治疗三叉神经痛的有效方法之一.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号